Lymphotoxin β receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of nf-κb activation

Carcinogenesis

Volumn 34, Issue 5, 2013, Pages 1105-1114

  Hu, Xiaolin ^a   Zimmerman, Mary A ^a   Bardhan, Kankana ^a   Yang, Dafeng ^a   Waller, Jennifer L ^a   Liles, Georgia B ^a   Lee, Jeffrey R ^a,b   Pollock, Raphael ^c   Lev, Dina ^c   Ware, Carl F ^d   Garber, Ellen ^e   Bailly, Veronique ^e   Browning, Jeffrey L ^e   Liu, Kebin ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BURNHAM INSTITUTE   (United States)

^e BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; CASPASE; CASPASE 3; CASPASE 8; CYTOCHROME C; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN; LYMPHOTOXIN BETA; LYMPHOTOXIN BETA RECEPTOR; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOFT TISSUE SARCOMA;

ANIMALS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; COLONIC NEOPLASMS; HUMANS; LIGANDS; LYMPHOTOXIN BETA RECEPTOR; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; NF-KAPPA B; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

EID: 84877136981     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt014     Document Type: Article

References (60)

1. Rooney,I.A. et al. (2000) The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J. Biol. Chem., 275, 14307-14315.
2. Zhai,Y. et al. (1998) LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J. Clin. Invest., 102, 1142-1151.
3. Kashii,Y. et al. (1999) Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J. Immunol., 163, 5358-5366.
4. Lu,G. et al. (2002) Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-α1β2, Fas ligand, and TNF-related apoptosis-inducing ligand. J. Immunol., 168, 1831-1839.
5. You,R.I. et al. (2006) Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-DeltaEx3. Cancer Res., 66, 3051-3061.
6. Lukashev,M. et al. (2006) Targeting the lymphotoxin β receptor with agonist antibodies as a potential cancer therapy. Cancer Res., 66, 9617-9624.
7. Yang,D. et al. (2007) Targeting lymphotoxin beta receptor with tumorspecific T lymphocytes for tumor regression. Clin. Cancer Res., 13, 5202-5210.
8. Dobrzanski,M.J. et al. (2004) Effector cell-derived lymphotoxin alpha and Fas ligand, but not perforin, promote Tc1 and Tc2 effector cell-mediated tumor therapy in established pulmonary metastases. Cancer Res., 64, 406-414.
9. Winter,H. et al. (2007) Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptor. J. Transl. Med., 5, 14.
10. Ware,C.F. (2005) Network communications: lymphotoxins, LIGHT, and TNF. Annu. Rev. Immunol., 23, 787-819.
11. Haybaeck,J. et al. (2009) A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell, 16, 295-308.
12. Pikarsky,E. et al. (2004) NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature, 431, 461-466.
13. Ammirante,M. et al. (2010) B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature, 464, 302-305.
14. Chen,F. et al. (2007) Nuclear factor-κB, an unappreciated tumor suppressor. Cancer Res., 67, 11093-11098.
15. Klein,U. et al. (2011) The two faces of NF-κB signaling in cancer development and therapy. Cancer Cell, 20, 556-558.
16. Daller,B. et al. (2011) Lymphotoxin-β receptor activation by lymphotoxin-α1β2 and LIGHT promotes tumor growth in an NFκB-dependent manner. Int. J. Cancer, 128, 1363-1370.
17. van Horssen,R. et al. (2006) TNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist, 11, 397-408.
18. Balkwill,F. (2009) Tumour necrosis factor and cancer. Nat. Rev. Cancer, 9, 361-371.
19. Mackay,F. et al. (1997) Cytotoxic activities of recombinant soluble murine lymphotoxin-α and lymphotoxin-αβ complexes. J. Immunol., 159, 3299-3310.
20. Liu,F. et al. (2011) TNFα cooperates with IFN-γ to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis. PLoS ONE, 6, e16241.
21. Hu,X. et al. (2011) IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia. Cancer Res., 71, 2882-2891.
22. Yang,D. et al. (2008) Downregulation of IFN-γR in association with loss of Fas function is linked to tumor progression. Int. J. Cancer, 122, 350-362.
23. Zimmerman,M. et al. (2010) IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells. PLoS ONE, 5, e14076.
24. Luo,J.L. et al. (2004) Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression. Cancer Cell, 6, 297-305.
25. Liu,F. et al. (2012) NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J. Biol. Chem., 287, 25530-25540.
26. McGough,J.M. et al. (2008) DNA methylation represses IFN-γ-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells. Mol. Cancer Res., 6, 1841-1851.
27. Mauri,D.N. et al. (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity, 8, 21-30.
28. Janjic,B.M. et al. (2002) Innate direct anticancer effector function of human immature dendritic cells. I. Involvement of an apoptosis-inducing pathway. J. Immunol., 168, 1823-1830.
29. Browning,J.L. et al. (1996) Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med., 183, 867-878.
30. Wu,M.Y. et al. (1999) The cytoplasmic domain of the lymphotoxinbeta receptor mediates cell death in HeLa cells. J. Biol. Chem., 274, 11868-11873.
31. Chen,M.C. et al. (2003) The role of apoptosis signal-regulating kinase 1 in lymphotoxin-beta receptor-mediated cell death. J. Biol. Chem., 278, 16073-16081.
32. Force,W.R. et al. (1997) Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-beta receptor. J. Biol. Chem., 272, 30835-30840.
33. Clark,M.A. et al. (2005) Soft-tissue sarcomas in adults. N. Engl. J. Med., 353, 701-711.
34. Ito,D. et al. (1999) Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment. J. Immunol., 163, 2809-2815.
35. Kuprash,D.V. et al. (2008) Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice. Cancer Lett., 268, 70-75.
36. Zhou,P. et al. (2009) Targeting lymphotoxin-mediated negative selection to prevent prostate cancer in mice with genetic predisposition. Proc. Natl Acad. Sci. U.S.A., 106, 17134-17139.
37. Lo,J.C. et al. (2007) Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science, 316, 285-288.
38. VanArsdale,T.L. et al. (1997) Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB. Proc. Natl Acad. Sci. U.S.A., 94, 2460-2465.
39. Kuai,J. et al. (2003) Endogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosis. J. Biol. Chem., 278, 14363-14369.
40. Kim,Y.S. et al. (2005) TRAF2 plays a key, nonredundant role in LIGHTlymphotoxin beta receptor signaling. Mol. Cell. Biol., 25, 2130-2137.
41. Wilson,C.A. et al. (2002) Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ., 9, 1321-1333.
42. Chen,M.C. et al. (2000) Overexpression of bcl-2 enhances LIGHT- and interferon-gamma-mediated apoptosis in Hep3BT2 cells. J. Biol. Chem., 275, 38794-38801.
43. Zhang,M. et al. (2003) LIGHT sensitizes IFNγ-mediated apoptosis of MDA-MB-231 breast cancer cells leading to down-regulation of antiapoptosis Bcl-2 family members. Cancer Lett., 195, 201-210.
44. Brady,R.R. et al. (2011) c-Src dependency of NSAID-induced effects on NF-κB-mediated apoptosis in colorectal cancer cells. Carcinogenesis, 32, 1069-1077.
45. Stark,L.A. et al. (2007) Aspirin activates the NF-κB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer. Carcinogenesis, 28, 968-976.
46. Vince,J.E. et al. (2007) IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell, 131, 682-693.
47. Petersen,S.L. et al. (2007) Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell, 12, 445-456.
48. Varfolomeev,E. et al. (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell, 131, 669-681.
49. Wang,Y. et al. (2002) NF-κB2 p100 is a pro-apoptotic protein with antioncogenic function. Nat. Cell Biol., 4, 888-893.
50. Ishikawa,H. et al. (1997) Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-κB2. J. Exp. Med., 186, 999-1014.
51. Chien,Y. et al. (2011) Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev., 25, 2125-2136.
52. Jing,H. et al. (2011) Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations. Genes Dev., 25, 2137-2146.
53. Crescenzi,E. et al. (2011) NF-κB-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells. Oncogene, 30, 2707-2717.
54. Karl,S. et al. (2009) Identification of a novel pro-apopotic function of NF-κB in the DNA damage response. J. Cell. Mol. Med., 13, 4239-4256.
55. Jennewein,C. et al. (2012) Identification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells. Oncogene, 31, 1468-1474.
56. Thoms,H.C. et al. (2010) Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination. Cancer Res., 70, 139-149.
57. He,G. et al. (2010) Hepatocyte IKKβ/NF-κB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell, 17, 286-297.
58. Luedde,T. et al. (2007) Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell, 11, 119-132.
59. Maeda,S. et al. (2005) IKKbeta couples hepatocyte death to cytokinedriven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell, 121, 977-990.
60. Yang,D. et al. (2012) Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo. J. Immunol., 188, 4441-4449.